VAX4ASF – NEW TECHNOLOGIES FOR AFRICAN SWINE FEVER VACCINES

African swine fever (ASF) threatens pigs and wild boar populations across Europe. The disease, caused by the ASF virus (ASFV), poses significant challenges due to its diverse variants and the limited efficacy of traditional vaccines. Current measures struggle to contain ASF outbreaks, leading to economic losses and significant animal welfare concerns. In this context, the EU-funded VAX4ASF project aims to provide a definitive, effective and safe solution against the highly contagious, unpredictable and complex ASFV. The project seeks to innovate based on previous vaccination approaches and strategies with potential for success. Moreover, it introduces novel virus epidemiology models and control strategies, fostering better transmission comprehension.